14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28943331 | Impact of Granulocyte-colony Stimulating Factor on Bleomycin-induced Pneumonitis in Chemotherapy-treated Germ Cell Tumors. | 2017 Sep 4 | 3 |
2 | 29340124 | The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD. | 2017 Oct 1 | 1 |
3 | 23597142 | Granulocyte colony-stimulating factor as secondary prophylaxis of febrile neutropenia in the management of advanced-stage Hodgkin lymphoma treated with adriamycin, bleomycin, vinblastine and dacarbazine chemotherapy: a decision analysis. | 2014 Jan | 1 |
4 | 22296221 | Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia. | 2012 May | 3 |
5 | 22442961 | [Effects of granulocyte colony-stimulating factor on experimental bleomycin-induced pulmonary fibrosis]. | 2012 | 2 |
6 | 16120623 | Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF. | 2005 Sep | 1 |
7 | 12771616 | Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. | 2003 May | 1 |
8 | 12844025 | [Acute respiratory distress syndrome due to pneumonitis following intrathecal methotrexate administration]. | 2003 Apr | 1 |
9 | 11378548 | Secondary prophylactic G-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD. | 2001 Apr | 1 |
10 | 10229865 | Bleomycin stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activity. | 1999 May 15 | 1 |
11 | 10362718 | Bleomycin stimulates lung epithelial cells to release neutrophil and monocyte chemotactic activities. | 1999 Jun | 1 |
12 | 9118704 | Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor. | 1997 Mar | 2 |
13 | 7513778 | Possible toxicity with the association of G-CSF and bleomycin. | 1994 May 14 | 1 |
14 | 7524599 | Serious pulmonary complications in patients receiving recombinant granulocyte colony-stimulating factor during BACOP chemotherapy for aggressive non-Hodgkin's lymphoma. | 1994 Nov | 1 |